Companies Dominating the Cardiac Implants Landscape
- Boston Scientific Corporation
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- BIOTRONIK SE & Co., KG
- ZOLL Medical Corporation
- Medtronic plc
- LivaNova PLC
- Abbott Laboratories
- MEDICO S.R.L.
- Lepu Medica
Browse Key Market Insights with Data Illustration:
In the News
-
Boston Scientific Corporation acquired clearance from the U.S. Food and Drug Administration (FDA) for its EMBOLD Fibered Detachable Coil that decreases the rate of peripheral vasculature blood flow.
-
BIOTRONIK, Inc. received approval of Renamic New, a software programmer for cardiac rhythm management devices, from the U.S. Food and Drug Administration (FDA).
